Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Caspers, Patrick
Etlinger, Howard
Matile, Hugues
Pink, J.Richard
Stüber, Dietrich
and
Takács, Béla
1991.
A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1.
Molecular and Biochemical Parasitology,
Vol. 47,
Issue. 2,
p.
143.
Jacobs, Paul
Massaer, Marc
Heinderyckx, Michel
Milican, Fabienne
Gilles, Pascal
van Opstal, Omer
Voet, Pierre
Gheysen, Dirck
and
Bollen, Alex
1991.
Plasmodium falciparum: recombinant baculoviruses direct the expression of circumsporozoite proteins in Spodoptera frugiperda cell cultures.
Molecular Biology Reports,
Vol. 15,
Issue. 2,
p.
73.
Gibson, Helen L.
Tucker, Jeffrey E.
Kaslow, David C.
Krettli, Antoniana U.
Collins, William E.
Kiefer, Michael C.
Bathurst, Ian C.
and
Barr, Philip J.
1992.
Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax.
Molecular and Biochemical Parasitology,
Vol. 50,
Issue. 2,
p.
325.
Zheng, Biao
Brett, Sara J.
Tite, John P.
Lifely, M. Robert
Brodie, Thomas A.
and
Rhodes, John
1992.
Galactose Oxidation in the Design of Immunogenic Vaccines.
Science,
Vol. 256,
Issue. 5063,
p.
1560.
RILEY, E. M.
ALLEN, S. J.
WHEELER, J. G.
BLACKMAN, M. J.
BENNETT, S.
TAKACS, B.
SCHONFELD, H. ‐J.
HOLDER, A. A.
and
GREENWOOD, B. M.
1992.
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (Pf MSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.
Parasite Immunology,
Vol. 14,
Issue. 3,
p.
321.
Chappel, Jonathan A.
and
Holder, Anthony A.
1993.
Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1.
Molecular and Biochemical Parasitology,
Vol. 60,
Issue. 2,
p.
303.
Blackman, M.J.
and
Holder, A.A.
1993.
Use of a recombinant baculovirus product to measure naturally-acquired human antibodies to disulphide-constrained epitopes on theP. falciparummerozoite surface protein-1 (MSP1).
FEMS Immunology & Medical Microbiology,
Vol. 6,
Issue. 4,
p.
307.
Bathurst, Ian C.
Gibson, Helen L.
Kansopon, Joe
Hahm, Benjamin K.
Green, Kim M.
Chang, Sandra P.
Hui, George S.N.
Siddiqui, Wasim A.
Inselburg, Joseph
Millet, Pascal
Quakyi, Isabella A.
Kaslow, David C.
and
Barr, Philip J.
1993.
An experimental vaccine cocktail for Plasmodium falciparum malaria.
Vaccine,
Vol. 11,
Issue. 4,
p.
449.
HOLDER, ANTHONY A.
1993.
Developments with Anti‐Malarial Vaccines.
Annals of the New York Academy of Sciences,
Vol. 700,
Issue. 1,
p.
7.
Daly, T M
and
Long, C A
1993.
A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.
Infection and Immunity,
Vol. 61,
Issue. 6,
p.
2462.
Lockyer, M. J.
Cooper, H.
Tite, J.
Rowan, W.
and
Crowe, J. S.
1993.
Immunogenicity of a hybridPlasmodium falciparum, malaria antigen.
Parasitology,
Vol. 106,
Issue. 5,
p.
451.
Haeseleer, Françoise
Pollet, Jean-François
Haumont, Michèle
Bollen, Alex
and
Jacobs, Paul
1993.
Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria.
Molecular and Biochemical Parasitology,
Vol. 57,
Issue. 1,
p.
117.
RILEY, E. M.
MORRIS‐JONES, S.
BLACKMAN, M. J.
GREENWOOD, B. M.
and
HOLDER, A. A.
1993.
A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.
Parasite Immunology,
Vol. 15,
Issue. 9,
p.
513.
LING, I. T.
OGUN, S. A.
and
HOLDER, A. A.
1994.
Immunization against malaria with a recombinant protein.
Parasite Immunology,
Vol. 16,
Issue. 2,
p.
63.
SPETZLER, JANE C.
RAO, CHANG
and
TAM, JAMES P.
1994.
A novel strategy for the synthesis of the cysteine‐rich protective antigen of the malaria merozoite surface protein (MSP‐1).
International Journal of Peptide and Protein Research,
Vol. 43,
Issue. 4,
p.
351.
Chappel, J A
Egan, A F
Riley, E M
Druilhe, P
and
Holder, A A
1994.
Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.
Infection and Immunity,
Vol. 62,
Issue. 10,
p.
4488.
Longacre, Shirley
Mendis, Kamini N.
and
David, Peter H.
1994.
Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus.
Molecular and Biochemical Parasitology,
Vol. 64,
Issue. 2,
p.
191.
SHAI, SHAFRIRA
BLACKMAN, MICHAEL J.
and
HOLDER, ANTHONY A.
1995.
Epitopes in the 19kDa fragment of the Plasmodium falciparum major merozoite surface protein‐1 (PfMSP‐119) recognized by human antibodies.
Parasite Immunology,
Vol. 17,
Issue. 5,
p.
269.
RHODES, JOHN
ZHENG, BIAO
and
MORRISON, CHRISTOPHER A.
1995.
Galactose Oxidation as a Potent Vaccine Adjuvant Strategy.
Annals of the New York Academy of Sciences,
Vol. 754,
Issue. 1,
p.
169.
LING, I.T.
OGUN, S.A.
and
HOLDER, A.A.
1995.
The combined epidermal growth factor‐like modules of Plasmodium yoelii Merozoite Surface Protein‐1 are required for a protective immune response to the parasite.
Parasite Immunology,
Vol. 17,
Issue. 8,
p.
425.